RE-BVS – Piemonte Repository

Sfoglia per AUTORE
TARELLA C
Collezione AO Cuneo

Items : 9

AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia. in Cancer / Cancer. 2023 Apr 1;129(7):992-1004. doi: 10.1002/cncr.34608. Epub 2023 Jan 24.

2023
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Martinelli G; Rossi G; Volpi R; Sciumè M; Tarella C; Marconi G; Federico V; Romano A; Cardinali V; Gigli F; Roncoroni E; Ferrara F; Maurillo L; Nanni J; Rivellini F; Cascavilla N; Fianchi L; Cilloni D; Lanza F; Abruzzese E; Martini V; Lunghi M; Molteni A; Gottardi M; Salutari P; Cairoli R; Borlenghi E; Basilico CM; Manfra I; et alii...

Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term. in Bone marrow transplantation / Bone Marrow Transplant. 2021 Oct;56(10):2606-2609. doi: 10.1038/s41409-021-01391-x. Epub 2021 Jul 7.

2021
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Corradini P; Magni M; Ladetto M; Ferrero S; Rossi A; Barbui AM; Tarella C; Rambaldi A; Rigacci L; Gianni AM; Castellino C; Nicoli P; Ferreri AJM; Chiappella A; Benedetti F; Vitolo U; Patti C; Costa A; Evangelista A; Devizzi L; Mian M; Cortelazzo S;

Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy. in Hematological oncology / Hematol Oncol. 2020 Oct;38(4):501-508. doi: 10.1002/hon.2775. Epub 2020 Jul 30.

2020
AO Cuneo
AO Ordine Mauriziano

Gianni AM; Gallamini A; Corradini P; Galbiati M; Ferreri AJM; Farina L; Zanotti R; Cimminiello M; Tarella C; Gottardi D; Guidetti A; Trentin L; Sorasio R; Romano A; Patti C; Rossi A; Taverna F; Rambaldi A; Pavoni C; Mazzocchi A; Viviani S;

Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 Nov 20;38(33):3905-3913. doi: 10.1200/JCO.20.00935. Epub 2020 Sep 18.

2020
AO Cuneo

Mulé A; Viero P; Schiavotto C; Cimminiello M; Zanotti R; Pavoni C; Sorasio R; Chauvie S; Battistini R; Gini G; Trentin L; Bolis S; Viviani S; Oppi S; Cantonetti M; Romano A; Picardi M; Patti C; Rossi A; Gallamini A; Fallanca F; Ficola U; Tarella C; Guerra L; Rambaldi A;

The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET-2-adapted HD0607 trial. in Cancer medicine / Cancer Med. 2020 Dec;9(23):8735-8746. doi: 10.1002/cam4.3396. Epub 2020 Nov 6.

2020
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Rambaldi A; Gallamini A; Massimo Gianni A; Biggi A; Chauvie S; Viero P; Ferreri AJM; Gini G; Schiavotto C; Zanotti R; Parvis G; Corradini P; Cimminiello M; Gavarotti P; Bolis S; Zoli V; Trentin L; La Nasa G; Cantonetti M; Picardi M; Rossi A; Patti C; Viviani S; Di Raimondo F; Tarella C; Pavoni C; Romano A;

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2018 Feb 10;36(5):454-462. doi: 10.1200/JCO.2017.75.2543. Epub 2018 Jan 23.

2018
AO Cuneo
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Rambaldi A; Gianni AM; Pavoni C; Chauvie S; Bergesio F; Prosperini G; Chiaravalloti A; Gregianin M; Ficola U; Fallanca F; Biggi A; Avigdor A; Billio A; Miglino M; Viero P; Ferreri AJM; Gini G; Zanotti R; Parvis G; Schiavotto C; Cimminiello M; Corradini P; Gavarotti P; Battistini R; Gottardi D; Rapezzi D; Bolis S; Trentin L; La Nasa G; et alii...

Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2016 Nov 20;34(33):4015-4022. doi: 10.1200/JCO.2016.67.2980. Epub 2016 Oct 31.

2016
AO Cuneo
AOU Città della Salute di Torino

Rambaldi A; Boschini C; Delaini F; Masciulli A; Pileri S; Tabanelli V; Bruna R; Chilosi M; Falorio S; Flenghi L; Frezzato M; Trentin L; Gini G; La Nasa G; Benedetti F; Ferreri AJ; Di Raimondo F; Castellino C; Negri G; Piccin A; Billio A; Zoli V; Zanni M; Mulé A; Patti C; Di Nicola M; Corradini P; Gritti G; Rossi A; et alii...

Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma. in Leukemia / Leukemia. 2014 Sep;28(9):1885-91. doi: 10.1038/leu.2014.79. Epub 2014 Feb 20.

2014
AO Cuneo

Corradini P; Vitolo U; Rambaldi A; Miceli R; Patriarca F; Gallamini A; Olivieri A; Benedetti F; Todeschini G; Rossi G; Salvi F; Bruno B; Baldini L; Ferreri A; Patti C; Tarella C; Pileri S; Dodero A;

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. in Blood / Blood. 2007 Oct 1;110(7):2316-23. doi: 10.1182/blood-2007-02-074641. Epub 2007 Jun 20.

2007
AO Cuneo

Secondo V; Rigacci L; Pinto A; Manna A; Levis A; Tucci A; Specchia MR; Billio A; Patti C; Zaja F; Gallamini A; Iannitto E; Zoli V; Torchio P; Pileri S; Tarella C;